![Georgia Today artwork](https://is2-ssl.mzstatic.com/image/thumb/Podcasts124/v4/bb/ed/42/bbed42dd-35b4-6a0d-8e1c-626e58f1334d/mza_7983243848004069219.jpeg/100x100bb.jpg)
The Emory University science lab behind what could be a gamechanging COVID-19 pill.
Georgia Today
English - October 08, 2021 01:19 - 19 minutes - 26.8 MBHealth & Fitness News Politics news politics health science media journalism georgia gpb npr atlanta Homepage Download Google Podcasts Overcast Castro Pocket Casts RSS feed
Drug company Merck is awaiting word on its emergency use-authorization application for its recently announced drug molnupiravir. If approved, the anti-viral drug developed at a lab at Emory University could become the first-ever pill to treat COVID-19. The latest Georgia Today podcast examines the journey that led to this potential breakthrough and its connection to Emory.